Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants

Pediatrics International

Volumn 45, Issue 6, 2003, Pages 665-670

  Su, Pen Hua ^a,b   Chen, Jia Yuh ^a   Su, Chi Ming ^a   Huang, Tzu Ching ^a   Lee, Hong Shen ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Ibuprofen; Indomethacin; Patent ductus arteriosus

Indexed keywords

CREATININE; IBUPROFEN LYSINE; INDOMETACIN; NITROGEN;

AIRWAY PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; BREATHING; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; LEUKOMALACIA; LIGATION; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; OXYGEN SUPPLY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; RETINOPATHY; STOMACH HEMORRHAGE; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; IBUPROFEN; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFUSIONS, INTRAVENOUS; MALE; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 1642521773     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2003.01797.x     Document Type: Article

References (35)

1. The Vernont-Oxford Trials Network. Very low birth weight outcomes for 1990. Pediatrics 1993, 91: 540-5.
2. Cotton RB. The relationship of symptomatic patent ductus arteriosus to respiratory distress in premature newborn infants. Clin. Perinatol. 1987; 14: 621-33
3. Clyman RI. Patent ductus arteriosus in the premature infant. In: Taeusch HW, Ballard RA, eds. Avery's Disease of the Newborn, 7th edn. WB Saunders, Philadelphia, 1998: 699-710.
4. Clyman RI, Narayanan M. Patent ductus arteriosus: a physiologic basis for current treatment practices. In: Hansen TN, McIntosh N, eds. Current Topics in Neonatology, Number 4. WB Saunders, Philadelphia, 2000: 72-91.
5. Bell EF, Warburton D, Stonestreet BS, Oh W. Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N. Engl. J. Med. 1978; 302: 598-655.
6. Cotton RB, Lindstrom DP, Stahlman MT. Early prediction of symptomatic patent ductus arteriosus from perinatal risk factors. A discriminant analysis model. Acta Pediatr. Scand. 1981; 70: 723-7.
7. Friedman WF, Hirschklaw MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N. Engl. J. Med 1976; 95: 526-9.
8. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J. Pediatr. 1983; 102: 895-906.
9. Yeh TF, Car I. Pharmacologic closure of patent ductus arteriosus. In: Yeh TF, ed. Neonatal Therapeutics, 2nd edn. Mosby Year Book, St Louis: 1991; 123-38.
10. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent dutus arteriosus. Pediatr. Res. 2000; 47: 36-42.
11. Carolis MPD, Romagnoli C, Polimeni V et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur. J. Pediatr. 2000; 159: 364-8.
12. Dani C, Bertin G, Reali MF et al. Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants. Acta Pediatr. 2000; 89: 1369-74.
13. Overmeire BV, Smets K, Lecoutere D et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N. Engl. J. Med. 2000; 343: 674-81.
14. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J. Pediatr. 1997; 131: 549-54.
15. Morsca F, Bray M, Colnagb MR, Fumagalli M, Compagnoni G. Cerebral vasoreactivity to arterial carbon dioxide tension in preterm infants: The effect of ibuprofen. J. Pediatr. 1999; 135: 644-6.
16. Romagnoli C, Carolis MPD, Papacci P. Effect of prophylactic ibuprofen on cerebral and renal hemodynamics in very preterm neonates. Clin. Pharmacol. Ther. 2000; 67: 673-83.
17. Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF. Effect of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J. Pediatr. 1999; 135: 733-8.
18. Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Prostanoids determine the range of cerebral blood flow autoregulation of newborn piglets. Stroke 1990; 21: 777-84.
19. Chemtob S, Roy MS, Abran D, Fernandez H, Harma DR. Prevention of post-asphyxial increase in lipid peroxides and retinal function deterioration in the newborn pig by inhibition of cyclooxygenase activity and free radical generation. Pediatr. Res. 1993; 33: 336-40.
20. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birthweights less than 1500 g. J. Pediatr. 1978; 92: 529-34.
21. Shennan AT, Dunn MS, Ohlesson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: predication from oxygen requirement in the neonatal period. Pediatrics 1998; 825: 527-32.
22. Anonymous. An international classification of retinopathy of prematurity. Pediatrics 1984; 74: 127-33.
23. Drummond WH. Ductus arteriosus. In: Spitzer AR, ed. Intensive Care of the Fetus and Neonate. Mosby-Year Book, St Louis, 1996, 760-71.
24. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N. Engl. J. Med. 1976; 295: 530-33.
25. Nakamura T, Tamura M, Kadowaki S, Sasano T. Low-dose continuous indomethacin in early days of age reduce the incidence of symptomatic patent ductus arteriosus without adverse effects. Am. J. Perinatol. 2000; 17: 271-5.
26. Schmidt B, Davis P, Moddemann D et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N. Engl. J. Med. 2001; 344: 1966-72.
27. Couser RJ, Hoekstra RE, Ferrara TB, Wright GB, Cabalka AK, Connett JE. Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. Arch. Pediatr. Adolesc. Med. 2000; 154: 598-602.
28. Tyson JE. Does indomethacin prophylaxis benefit extremely low birth weight infants? Result of a placebo-controlled multicenter trial. Pediatr. Res. 2002; 51: P1.
29. Perez CA, Bustorff-Silva JM, Villasenor E., Fonkalsrud EW, Atkinson JB. Surgical ligation of patent ductus arteriosus in very low birth weight infants: Is it safe? Am. J. Surg. 1998; 64: 1007-9.
30. Wagner HR, Ellison RC, Zierler S et al. Surgical closure of patent ductus arteriosus in 268 preterm infants. J. Thorac. Cardiovasc. Surg. 1984; 87: 870-75.
31. Haneda N, Masue M, Tasaka M, Fukui C, Saito K, Yamaguchi S. Transcatheter closure of patent ductus arteriosus in an infant weighing 1180g. Pediatr. Int. 2001; 43: 176-8.
32. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants. JAMA 1996; 275: 539-44.
33. Malcolm DD, Segar JL, Robillard E, Chemtob S. Indomethacin compromises hemodynamics during posititive-pressure ventilation, independently of prostanoids. J. Appl. Physiol. 1993; 74: 1672-8.
34. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch. Dis. Child. 1997; 76: 179-84.
35. Hosono S, Ohno T, Kimoto H, Nagoshi R, Shimizu M, Nozawa M. Reduction in blood glucose values following indomethacin therapy for patent ductus arteriosus. Pediatr. Int. 1999; 41: 525-8.